These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6170360)

  • 1. [Physico-chemical and immunologic properties of the tissue DNA of mice with oncornavirus-induced leukemia].
    Chamova KG; Perelaznyĭ AA; Guseva NI
    Biull Eksp Biol Med; 1981 Jul; 92(7):60-2. PubMed ID: 6170360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A contribution to immunological specificity of DNA in leukosis.
    Guberniev MA; Chamova KG; Perelaznii AA; Shumilova SL
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(2):230-6. PubMed ID: 51870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement fixation in conventional and regressing virus-induced murine leukemia.
    Rich MA; Karl S; Clymer R
    J Immunol; 1971 Jun; 106(6):1488-92. PubMed ID: 4326129
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of group- and type-specific antigens in the process of development of viral murine leukemias].
    Gurtsevich VE; Mazurenko NP
    Vopr Onkol; 1973; 19(1):66-70. PubMed ID: 4121908
    [No Abstract]   [Full Text] [Related]  

  • 5. Group- and type-specific antigens in mouse leukaemia induced by Friend, Mazurenko and Rauscher viruses.
    Mazurenko NP; Gurtsevich VE
    Neoplasma; 1972; 19(4):277-82. PubMed ID: 4341019
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors.
    Rogers MJ; Galetto G; Hearing VJ; Siwarski DF; Law LW
    J Immunol; 1984 Jun; 132(6):3211-7. PubMed ID: 6202777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The neoantigens of cancer cells and their significance].
    Mathé G; Amiel JL; Doré JF
    Rev Fr Etud Clin Biol; 1968 Dec; 13(10):937-40. PubMed ID: 4308925
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems.
    McCoy JL; Fefer A; Glynn JP
    Cancer Res; 1967 Oct; 27(10):1743-8. PubMed ID: 6064953
    [No Abstract]   [Full Text] [Related]  

  • 9. [A comparative study of the stabilized secondary structure and hydrodynamic properties of DNA from healthy and leukemic tissue].
    Mazepa IV
    Vopr Med Khim; 1993; 39(4):45-8. PubMed ID: 8379115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of immunizing properties as well as interferogenicity of some murine leukemia viruses.
    Mazurenko NP; Revazova ES
    Arch Geschwulstforsch; 1970; 35(4):308-14. PubMed ID: 4325787
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of virus-specific RNA in cells of mice infected with Mazurenko and Rauscher viruses].
    Komissarova EV; Kiselev FL
    Biull Eksp Biol Med; 1980 Apr; 89(4):446-9. PubMed ID: 6248149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprotective determinants in friend murine leukemia virus envelope protein.
    Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
    Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative spleen colony assay method for tumor cells induced by Friend leukemia virus infection in mice.
    Thomson S; Axelrad AA
    Cancer Res; 1968 Oct; 28(10):2104-14. PubMed ID: 5696939
    [No Abstract]   [Full Text] [Related]  

  • 16. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
    Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
    J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical aspects of leukemia virus-induced immunosuppression: effect of Friend disease virus on spleen nucleases and nucleic acids.
    Chakrabarty AK; Friedman H; Ceglowski WS
    Cancer Res; 1970 Mar; 30(3):617-24. PubMed ID: 5425287
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement fixation and tissue culture assays for mouse leukemia viruses.
    Hartley JW; Rowe WP; Capps WI; Huebner RJ
    Proc Natl Acad Sci U S A; 1965 May; 53(5):931-8. PubMed ID: 4287967
    [No Abstract]   [Full Text] [Related]  

  • 19. [Change in the topologic bond number of closed DNA loops during differentiation of mouse erythroleukemia cells].
    Glazer VM; Luchnik AN
    Dokl Akad Nauk SSSR; 1980; 250(5):1247-50. PubMed ID: 6929248
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activation of cellular genes as affected by Rauscher leukemia virus].
    Smirnova IA; Tatosian AG; Sherban SD; Butenko ZA
    Eksp Onkol; 1984; 6(6):31-3. PubMed ID: 6084587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.